---
title: "Danaher Corporation (DHR.US) — Company Overview"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/DHR.US/overview.md"
symbol: "DHR.US"
name: "Danaher Corporation"
parent: "https://longbridge.com/en/quote/DHR.US.md"
datetime: "2026-04-16T07:19:51.508Z"
locales:
  - [en](https://longbridge.com/en/quote/DHR.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DHR.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DHR.US/overview.md)
---

# Danaher Corporation (DHR.US) — Company Overview

## Basic Information

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | US Market |
| Address | 2200 Pennsylvania Avenue N.W., Suite 800W, Washington, District Of Columbia, United States |
| Website | [www.danaher.com](https://www.danaher.com) |

## Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands.

## Key Executives

| Name | Title |
|------|-------|
| Steven M. Rales | Co-Founder & Chairman |
| Rainer M. Blair | President, CEO & Director |
| Mitchell P. Rales | Co-Founder & Director |
| Jose-Carlos Gutierrez-Ramos | Senior VP & Chief Science Officer |
| Matthew R. McGrew | Executive Vice President |
| Linda Hefner Filler | Lead Independent Director |
| Teri L. List-Stoll | Independent Director |

## Major Shareholders

| Name | Ratio | Report Date |
|------|-------|-------------|
| The Vanguard Group, Inc. | 8.62% | 2025-12-31 |
| BlackRock, Inc. | 7.35% | 2025-12-31 |
| Steven M. Rales | 5.97% | 2026-03-01 |
| Mitchell P. Rales | 4.77% | 2026-03-01 |
| State Street Global Advisors, Inc. | 3.91% | 2025-12-31 |
| Capital Research and Management Company | 2.80% | 2025-12-31 |
| T. Rowe Price Group, Inc. | 2.43% | 2025-12-31 |
| FMR LLC | 2.40% | 2025-12-31 |
| Wellington Management Group LLP | 2.13% | 2025-12-31 |
| JP Morgan Asset Management | 1.96% | 2025-12-31 |

## Business Breakdown

| Segment | Revenue | Ratio |
|---------|---------|-------|
| Diagnostics | 9941000000 | 40.46% |
| Life Sciences Excl. Biotechnology | 7334000000 | 29.85% |
| Biotechnology | 7293000000 | 29.68% |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "Danaher Corporation Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "Diagnostics",
        "ratio": 40.46
      },
      {
        "segment": "Life Sciences Excl. Biotechnology",
        "ratio": 29.85
      },
      {
        "segment": "Biotechnology",
        "ratio": 29.68
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```

## Geographic Segments

| Region | Revenue | Ratio |
|--------|---------|-------|
| All Other | 11956000000 | 48.66% |
| United States | 9981000000 | 40.63% |
| China | 2631000000 | 10.71% |


---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**